Glutamine antagonists in chemotherapy.
D000328:Adult; D000613:Aminobutyrates / Q000494:pharmacology; D000818:Animals; D001215:Asparaginase / Q000037:antagonists & inhibitors; D001377:Azaserine / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D001391:Azo Compounds / Q000494:pharmacology; D002648:Child; D003980:Diazooxonorleucine / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D004347:Drug Interactions; D005974:Glutamate-Ammonia Ligase / Q000037:antagonists & inhibitors; D005972:Glutaminase / Q000627:therapeutic use; D005973:Glutamine / Q000037:antagonists & inhibitors* / Q000096:biosynthesis / Q000627:therapeutic use; D006801:Humans; D006901:Hydroxylysine / Q000494:pharmacology; D007938:Leukemia / Q000188:drug therapy; D007939:Leukemia L1210 / Q000188:drug therapy; D008099:Liver / Q000201:enzymology; D008717:Methionine Sulfoximine / Q000494:pharmacology; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy; D012343:RNA, Transfer / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D051381:Rats
D000613:Aminobutyrates; D001391:Azo Compounds; D004338:Drug Combinations; D003980:Diazooxonorleucine; D005973:Glutamine; D008717:Methionine Sulfoximine; D006901:Hydroxylysine; D001377:Azaserine; D012343:RNA, Transfer; D001215:Asparaginase; D005972:Glutaminase; D005974:Glutamate-Ammonia Ligase